Bill · H.Res. 342· House(119-HRES-342)
Recognizing the history of the drug diethylstilbestrol and the harm it has caused, and for other purposes.
- Introduced
- 4/21/2025
- Last activity
- 4/21/2025 — Referred to the House Committee on Energy and Commerce.
- Sponsored by
- James McGovern
- Cosponsors
- None
- Introduced
- In Committee
A House resolution is the House speaking for itself: stating a position, honouring someone, or setting its own rules. Adopting it is the whole process. Once the House agrees to it, it is officially the House's word; it is not a law, so the Senate and the President have no part in it.
What this bill would do
This resolution recognizes the history and harm caused by the drug diethylstilbestrol, known as DES. DES was approved by the Food and Drug Administration in the early 1940s and widely given to pregnant women until 1971 to prevent miscarriage. Exposure to DES has been linked to rare cancers, fertility and pregnancy complications, and other health challenges. The Food and Drug Administration banned its use during pregnancy in 1971 and has acknowledged the harm caused, but has not yet apologized. This measure supports designating a DES Awareness Week, recognizing the harm caused, restoring funding for the DES Follow-Up Study, and urging the Food and Drug Administration to issue a formal apology.
Yes· 3 of 8
Does this put more money into medical research?+4
The resolution explicitly supports the restoration of funding for the DES Follow-Up Study.
Would people over 65 be better off under this?+3
The resolution directly recognizes the long-term health challenges faced by older individuals and families impacted by DES use decades ago.
Would women be better off under this?+3
The resolution brings awareness and support to women and families who experienced reproductive health complications due to DES exposure.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
DES Awareness Week Support: Under Resolved, (1), the House of Representatives expresses support for designating ``DES Awareness Week'' from April 20 through 26, 2025, which brings attention to the history and health impacts of the drug.
-
Recognition of Harm: Under Resolved, (2), the resolution recognizes the history of the drug and the harm it has caused to individuals and families.
-
Study Funding: Under Resolved, (3), the resolution supports the restoration of funding for the DES Follow-Up Study, which could help track and understand health challenges related to the drug.
-
Call for Apology: Under Resolved, (4), the measure urges the Food and Drug Administration to issue a formal apology to the families impacted by diethylstilbestrol.
Potential Negative Impacts for People
- No Negative Impacts Identified: The provided text of the resolution does not contain any specific sections or provisions that outline negative consequences, burdens, or harms for individuals or groups of people in the United States.
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Hover a score for the reason it gave.
- Demographic And Interest Groups
- Good For Seniors+3Good For Women+3Good For Retirees+2
- Healthcare
- Increases Research Funding+4Improves Healthcare Access+3
- Education And Technology
- Increases Scientific Research Funding+3
- Governance And Ideology
- Improves Government Transparency+2
- Social Issues And Justice
- Improves Gender Equality+2
- 4/21/2025
- Submitted in House
- Referred to the House Committee on Energy and Commerce.